AI
Friday, September 21, 2012 7:19:58 AM
VPHM. ViroPharma And Halozyme Provide Update On Clinical Development Of Subcutaneous Cinryze® (C1 Esterase Inhibitor [Human]) With Recombinant Human Hyaluronidase (rHuPH20)
http://finance.yahoo.com/news/viropharma-halozyme-clinical-development-subcutaneous-110000399.html
http://finance.yahoo.com/news/viropharma-halozyme-clinical-development-subcutaneous-110000399.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
